Efficacy and Safety Study of FID 119515A
NCT01833117 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 75
Last updated 2018-06-29
Summary
The purpose of this study was to compare the effect of FID 119515A to Blink® Tears on the integrity of tear film in adults with a history of dry eye in both eyes.
Conditions
- Dry Eye
Interventions
- OTHER
-
FID 119515A
topical ocular drops
- OTHER
-
Blink® Tears
topical ocular drops
Sponsors & Collaborators
-
Alcon Research
lead INDUSTRY
Principal Investigators
-
Lisa Lindsey, PhD · Alcon Research
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-05-31
- Primary Completion
- 2013-06-30
- Completion
- 2013-06-30
More Related Trials
-
Artificial Tears Study in Mild to Moderate Dry Eye Patients
NCT00607776 ·Status: COMPLETED ·Phase: PHASE2
-
A Study Designed to Evaluate Tear Production
NCT06544707 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Evaluation of an Investigational Lipid Drop in Non-contact Lens Wearing Patients
NCT03995355 ·Status: COMPLETED
-
Clinical Evaluation of a Multidose Preservative-free Lubricating Eye Drops Contained in Novelia® Eye Dropper in Non-Contact Lens Wearing Patients
NCT05661851 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Investigate the Effect of 0.003% AR-15512 on Subjects With Dry Eye Disease
NCT06544694 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of Blink Tears and Systane Concomitant With Restasis for the Treatment of Dry Eye Symptoms
NCT00565669 ·Status: COMPLETED ·Phase: NA
-
Effects of NOV03 on the Tear Film
NCT05723770 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy of Nonsteroidal Anti-inflammatory Drugs in Treatment of Moderate and Severe Dry Eye Disease
NCT01562795 ·Status: COMPLETED ·Phase: NA
-
A Clinical Evaluation of an Investigational Lubricant Eye Gel (FID 115958D)
NCT01294956 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Safety and Tolerability of Investigational Ocular Lubricants
NCT05888519 ·Status: COMPLETED ·Phase: NA
-
Povidone-iodine 2% Eye Drop Versus Artificial Tear Drop for Treatment of Adenoviral Keratoconjunctivitis
NCT04041856 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Study of the Pharmacodynamic Activity of P-321 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Disease
NCT02824913 ·Status: TERMINATED ·Phase: PHASE2
-
Local Tolerability and Safety of Povidone K25 Eye Drops (Artificial Tears Containing Povidone) Versus Placebo in Healthy Volunteers
NCT00135824 ·Status: COMPLETED ·Phase: PHASE4
-
Tear Lipid Layer Thickness With Emollient Eye Drops
NCT03380624 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of the Safety and Tolerability of Ocular Lubricants
NCT06571656 ·Status: TERMINATED ·Phase: NA
-
Safety and Efficacy of Pilocarpine Ophthalmic Topical Cream for the Treatment of Dry Eye Disease
NCT05119920 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of the Effect of Repeated Usage on the Tear Film Characteristics of an Investigational Eye Drop in Dry Eye Sufferers
NCT01339936 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Phase II Study of AL-2178 (FID 109980) in the Treatment of Dry Eye
NCT00471419 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Acceptability of Two Lubricant Eye Drops
NCT00756678 ·Status: COMPLETED ·Phase: PHASE4
-
Effects of Two Tear Substitutes in Patients With Dry Eye Syndrome
NCT03211351 ·Status: COMPLETED ·Phase: NA
-
Evaluation of FID 114657 on Tear Film Lipid Layer Thickness
NCT00848068 ·Status: COMPLETED ·Phase: NA
-
HU007 Eye Drops in Patients With Dry Eye Syndrome
NCT04384991 ·Status: COMPLETED ·Phase: PHASE3
-
Trial of CF101 to Treat Patients With Dry Eye Disease
NCT01235234 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of Reflex Tear Production
NCT06565624 ·Status: TERMINATED ·Phase: NA
-
Dry Eye Disease Study With Brimonidine
NCT03418727 ·Status: COMPLETED ·Phase: PHASE2